Note: Occasionally, we bring you articles from guest editors that we think you will enjoy and benefit from. Today, you’ll hear from Carla Pasternak, Chief Investment Strategist of High-Yield Investing at StreetAuthority, as she discusses the criteria for the S&P 500’s dividend that is most likely to be cut. I hope you enjoy it!
Normally I’m [...]

[Read more →]

Note from Editor Elyse Andrews: Chloe Lutts, editor of Dick Davis Digest and Dick Davis Income Digest is back writing this month. This time Chloe discusses the boom in retail stocks and an investment for this trend. Enjoy!
As the editor of Dick Davis Digest and Dick Davis Income Digest, I do a lot of reading. [...]

[Read more →]

Two companies that have demonstrated steady, reliable growth in the past and boast talented management teams with visionary business plans are Teva Pharmaceutical and Walgreen.
Teva Pharmaceutical (TEVA) is based in Israel and develops, makes and sells generic and proprietary-branded (store brand) drugs. The company is one of the largest generic drug producing companies in the [...]

[Read more →]

Note from Cabot Wealth Advisory Editor Elyse Andrews: Occasionally, we bring you articles from guest editors that we think you will enjoy and benefit from. Today, you’re going to hear from Carla Pasternak, Chief Investment Strategist of High-Yield Investing at StreetAuthority, as she discusses how to find the safest dividend in the S&P 500 Index. [...]

[Read more →]

Note from Editor Elyse Andrews: Last month, you heard from Chloe Lutts, editor of Dick Davis Digest and Dick Davis Income Digest, for the first time. She’s back writing again, this time about America’s obesity epidemic and a company that’s working to build a healthier America. Enjoy!
—
Last month, First Lady Michelle Obama launched a campaign [...]

[Read more →]